| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |
| 07/10/2008 | US20080167306 Novel Heteroaryl Derivative |
| 07/10/2008 | US20080167305 Sodium channel moderators; antiarrhythmia agents; cardiovascular disorders; antiinflammatory agents; analgesics; antiarthritic agents; nervous system disorders; antiepileptic agents; psychological disorders;multiple sclerosis; irritable bowel syndrome |
| 07/10/2008 | US20080167304 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| 07/10/2008 | US20080167303 Aryl sulfamide derivatives and methods of their use |
| 07/10/2008 | US20080167302 Peptide Deformylase Inhibitors |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases |
| 07/10/2008 | US20080167299 menopause therapy; contraceptive; anticancer agents |
| 07/10/2008 | US20080167298 Medicaments for the treatment of chronic obstructive pulmonary disease |
| 07/10/2008 | US20080167297 Pyrimidine Derivatives for Use as Anticancer Agents |
| 07/10/2008 | US20080167296 Aids therapy; viricides |
| 07/10/2008 | US20080167295 Containing a nortropane ring, e.g., 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[2-hydroxy-3-(4-methanesulfonylpiperazin-1-yl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; 5-HT4 receptor agonists |
| 07/10/2008 | US20080167294 Cardiovascular disorders; liver disorders ; vascular system disorders; antiinflammatory agents; analgesics ; edema; hypotensive agents |
| 07/10/2008 | US20080167293 Pyrrolobenzodiazepines |
| 07/10/2008 | US20080167292 Compounds for inhibiting mitotic progression |
| 07/10/2008 | US20080167291 Neurogenesis by modulating angiotensin |
| 07/10/2008 | US20080167290 Particularly citalopram, escitalopram, fluoxetine, sertraline, paroxetine, fluvoxamine, venlafaxine, dapoxetine, nefazodone, imipramin, femoxetine or clomipramine; treatment of depression and other affective disorders |
| 07/10/2008 | US20080167289 Pyrimidinohydrodiazepinones, e.g., 2-(1,6-dihydro-4-methyl-6-oxopyridin-3-ylamino)-9-cyclopentyl-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one; especially c-Met kinase inhibitors; anticancer agents |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 07/10/2008 | US20080167286 Pharmaceutical compositions and their methods of use |
| 07/10/2008 | US20080167285 Bactericides; bacteriostats; therapy for bacteria infections |
| 07/10/2008 | US20080167284 Hair And/Or Scalp Care Compositions Incorporating Visnadin |
| 07/10/2008 | US20080167283 Nandrolone 17 Beta-Carbonates |
| 07/10/2008 | US20080167282 Particularly androgens, for the treatment of disorders resulting from use, especially abuse, of substances including intoxication, withdrawl, addiction, mental disorders, gambling, or recurrent criminal behavior. |
| 07/10/2008 | US20080167281 Benzocaine, antipyrine, aluminum acetate, acetic acid, and optionally a polycosanol such as 1-nonacosanol, an antiinflammatory agent, and/or aloe; free of cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
| 07/10/2008 | US20080167279 Multiple daily dosages containing at least 0.50 mg of levonorgestrel and an estrogen component, e.g., norgestimate, with less than 30 mcg EE equivalent; oral contraceptives and hormone replacement therapy |
| 07/10/2008 | US20080167278 Phytoestrogen (especially an isoflavone), a progestin, and an estrogen, prevent cancers such as epithelial ovarian cancer by inhibiting the conversion of normal and dysplastic ovarian epithelial cells to neoplastic cells via biologic effects unrelated to ovulation inhibition |
| 07/10/2008 | US20080167277 Treating plaque psoriasis or inverse psoriasis by topically administering phenethyl or benzyl 3,4-dihydroxycinnamate to inhibit a Signal Transducers and Activators of Transcription 3 signaling pathway; may also include a petroleum jelly or dimethyl sulfoxide solubilizer and a cell differentiation agent |
| 07/10/2008 | US20080167276 Multiple daily sequential dosages of a mixture of a progestin, genistein and an estrogen; contraceptives and hormone replacement therapy |
| 07/10/2008 | US20080167275 Composition containing progestin, phytoestrogen, estrogen and vitamin d compound |
| 07/10/2008 | US20080167274 Multiphasic hormonal regimen wherein at least one of the daily dosages has at least 0.5 mg of norgestrel and an estrogen component; prevent cancers such as epithelial ovarian cancer by inhibiting the conversion of normal and dysplastic ovarian epithelial cells to neoplastic cells |
| 07/10/2008 | US20080167273 Therapy against tetracycline-resistant organisms; bactericides; bacteriostats; escherichia; straphococcus; enterococcus; anticancer agents; antidiabetic agents |
| 07/10/2008 | US20080167272 Thalidomide metabolites and methods of use |
| 07/10/2008 | US20080167271 Pharmaceutical compositions comprising a bisphosphonate compound |
| 07/10/2008 | US20080167270 Anti-infective phosphonate analogs |
| 07/10/2008 | US20080167269 Hydrolysis resistant organomodified silylated ionic surfactants |
| 07/10/2008 | US20080167268 Particulate beta-glucan compositions for regulating dendritic cells |
| 07/10/2008 | US20080167267 Agent for Drug Clearance and Accelerator for Drug Clearance |
| 07/10/2008 | US20080167266 Process For Preparing An Iron Saccharose Complex |
| 07/10/2008 | US20080167265 Modulation of fr-alpha expression |
| 07/10/2008 | US20080167264 Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| 07/10/2008 | US20080167263 Methods for Modulating the Efficacy of Nucleic Acid Based Therapies |
| 07/10/2008 | US20080167262 Methods and compositions for diagnosing and treating prostate cancer |
| 07/10/2008 | US20080167261 Altered Recombinases for Genome Modification |
| 07/10/2008 | US20080167260 Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats |
| 07/10/2008 | US20080167259 Incorporating polynucleotides encoding fusion proteins comprising CFTR peptide and DNA binding domain of transcriptional activator that binds to site on detectable gene into host cell ; gene expressing; drug screening, high throughput assay; enhances dimerization of CFTR protein; cystic fibrosis |
| 07/10/2008 | US20080167258 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167256 Double-stranded RNA (siRNA) capable of suppressing expression of Skp-2 gene; small cell lung cancer |
| 07/10/2008 | US20080167255 4-biarylyl-1-phenylazetidin-2-ones |
| 07/10/2008 | US20080167254 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents |
| 07/10/2008 | US20080167245 Novel metastasis suppressor gene on human chromosome 8 |
| 07/10/2008 | US20080167242 Toll-like receptor agonists and antagonists and methods of use thereof |
| 07/10/2008 | US20080167230 treating asthma by administering a trefoil peptide, the human intestinal trefoil factor (ITF), cyclic peptides |
| 07/10/2008 | US20080167228 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167220 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 07/10/2008 | US20080167217 Aryl ketone compounds and compositions for delivering active agents |
| 07/10/2008 | US20080167216 for treating Parkinson's disease in a mammal, comprising:providing a quantity of a viral vector expressing an N-terminal of sonic hedgehog ("ShhN"); andadministering a therapeutically effective amount of the quantity of viral vector to the mammal. |
| 07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
| 07/10/2008 | US20080166780 Culturing thraustochytriales and fermenting docosahexaenoic, eicosapentaenoic and docosapentaenoic acids |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166765 Fungal cell wall synthesis gene |
| 07/10/2008 | US20080166750 Reducing toxicity associated with 6-mercaptopurine drug treatment via monitoring concentration of 6-thioguanine in blood; treating inflammatory bowel disease |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use |
| 07/10/2008 | US20080166438 Chromones As Therapeutic Agents |
| 07/10/2008 | US20080166433 Methods and Composition For Dietary Supplements |
| 07/10/2008 | US20080166431 Smooth-Feeling Wax-Based Compositions for Personal Care Preparations |
| 07/10/2008 | US20080166427 Method for Reducing Gastrointestinal Toxicity Due to the Administration of Tegafur |
| 07/10/2008 | US20080166423 Combination Medication for Treating the Effects of Stomach Acid Reduction Medication on Bone Integrity |
| 07/10/2008 | US20080166418 Krill oil compositions |
| 07/10/2008 | US20080166417 Method of Relieving or Avoiding Side Effect of Steroid |
| 07/10/2008 | US20080166416 Targeted, efficient release; dosing accuracy, well distributed in intestinal lumen; lipophilic matrix providing bioavailability |
| 07/10/2008 | US20080166414 Delivery particles having surface altering agent; transfection efficiency |
| 07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
| 07/10/2008 | US20080166408 Oral Dosage Form Comprising Rosiglitazone |
| 07/10/2008 | US20080166407 Tablets containing non-steroidal anti-inflammatory drug (aspirin), agent for reducing gastric acid secretion (omeprazole), thermoplastic hydrophilic polymer (polyoxyethylene glycol), microparticular excipient (microcrystalline cellulose), and cellulosic enteric coating |
| 07/10/2008 | US20080166406 Rapidly Disintegrating Dosage Form Comprising Magnesium Carbonate Heavy |
| 07/10/2008 | US20080166405 Abuse-resistant oral dosage forms and method of use thereof |
| 07/10/2008 | US20080166404 Bioadhesive drug formulations for oral transmucosal delivery |
| 07/10/2008 | US20080166402 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 07/10/2008 | US20080166400 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/10/2008 | US20080166398 Antifungal Compositions |
| 07/10/2008 | US20080166396 Thrombin domains; for preventing flight deep vein thrombosis or thrombosis in intermittent apheresis |
| 07/10/2008 | US20080166395 Pouches for nicotine replacement therapy; coconuts, flavors, herbs |
| 07/10/2008 | US20080166394 For reducing cancer risks |
| 07/10/2008 | US20080166391 Zero-order prolonged release coaxial implants |
| 07/10/2008 | US20080166389 Compositions and methods for treatment of hyperplasia |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166384 sanitizing a stethoscope head by providing a cover having a biocidal environment within a cavity of the stethoscope |
| 07/10/2008 | US20080166383 PVC (polyvinyl chloride); solves the problem of hypersensitivity to condom or glove; contains matrine and/or sodium ferulate |
| 07/10/2008 | US20080166382 Amphiphilic block copolymers and nanoparticles comprising the same |
| 07/10/2008 | US20080166380 Drug encapsulated polymer micelles formed from a block copolymer having a hydrophilic segment and hydrophobic segment, and has been subjected to high-pressure treatment; drug delivery |
| 07/10/2008 | US20080166378 Death receptor sensitizing compounds and methods of use therefor |
| 07/10/2008 | US20080166376 Nucleic acids, proteins and vectors containing a nucleotide sequence encoding a full-length or a truncated form of the 60kCRMP gene product of a strain of Chlamydia; vaccines |
| 07/10/2008 | US20080166371 HPV31(human papillomavirus) virus-like particles (VLPs); vaccines and drugs for preventing hepatitis |